Talaris Therapeutics, Inc.
Talaris Therapeutics, Inc. (TALS) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 103 transactions totaling $13.0M, demonstrating a bullish sentiment with $7.5M in net insider flow. The most recent transaction on Jul 3, 2023 involved a transaction of 11,786 shares valued at $36.3K.
TALS Insider Activity Summary
Who Is Buying TALS Stock?
No significant insider buying has been recorded for TALS in the recent period.
Who Is Selling TALS Stock?
No significant insider selling has been recorded for TALS in the recent period.
Is Talaris Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TALS is bullish with an Insider Alignment Score of 79/100 and a net flow of $7.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TALS Frequently Asked Questions
Understanding TALS Insider Activity
Insider trading at Talaris Therapeutics, Inc. (TALS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading TALS stock, having executed 103 transactions in the past 90 days. The most active insider is Capital Partners Iii, Llc Longitude (Executive), who has made 2 transactions totaling $4.0M.
Related Tools
Track Talaris Therapeutics, Inc. Insider Activity
Get notified when executives and directors at TALS file new Form 4 transactions